RISS 학술연구정보서비스

검색
다국어 입력

http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.

변환된 중국어를 복사하여 사용하시면 됩니다.

예시)
  • 中文 을 입력하시려면 zhongwen을 입력하시고 space를누르시면됩니다.
  • 北京 을 입력하시려면 beijing을 입력하시고 space를 누르시면 됩니다.
닫기
    인기검색어 순위 펼치기

    RISS 인기검색어

      KCI등재 SCOPUS

      Prognostic Factors for Improved Survival after Pulmonary Metastasectomy from Osteosarcoma

      한글로보기

      https://www.riss.kr/link?id=A104532874

      • 0

        상세조회
      • 0

        다운로드
      서지정보 열기
      • 내보내기
      • 내책장담기
      • 공유하기
      • 오류접수

      부가정보

      다국어 초록 (Multilingual Abstract)

      Purpose: The aim of this study was to evaluate the clinical characteristics and chestcomputed tomography (CT) images of the patients who underwent pulmonary metastasectomyfrom osteosarcoma, and to identify the prognostic factors associatedwith the improvement of survival.
      Materials and Methods: Fifty-nine patients with pulmonary metastases from osteosarcomawere included. The prognoses of the patients were assessed by 5-yearsurvival rate, after the pulmonary metastasectomy. The prognostic factors analyzedare as follows: age, sex, location of the primary osteosarcoma, disease-free interval(DFI) from the date of primary surgery to the date of pulmonary metastases on CT,number of pulmonary metastases, maximum diameter of largest pulmonary metastaticnodule, laterality (unilateral/bilateral), and location of pulmonary metastaticnodule(s). The log-rank test was used for univariate analyses, and the Cox proportionalhazards model was used for multivariate analyses.
      Results: The 5-year survival rate was 33.89%. Multivariate analyses revealed that aDFI > 12 months [p = 0.041, hazard ratio = 0.504, 95% confidence interval (CI) =0.254--1.001] and nodule unilaterality (p = 0.029, hazard ratio = 0.291, 95% CI =0.096--0.883) were the independent prognostic factors affecting the 5-year survival.
      The 5-year survival rates of patients with a DFI > 12 months and unilaterality ofthe metastatic nodule(s) increased to 44.11% and 39.28%, respectively.
      Conclusion: The prognostic factors associated with the improved survival afterpulmonary metastasectomy from osteosarcoma were the DFI > 12 months and theunilaterality of the metastatic nodules.
      번역하기

      Purpose: The aim of this study was to evaluate the clinical characteristics and chestcomputed tomography (CT) images of the patients who underwent pulmonary metastasectomyfrom osteosarcoma, and to identify the prognostic factors associatedwith the imp...

      Purpose: The aim of this study was to evaluate the clinical characteristics and chestcomputed tomography (CT) images of the patients who underwent pulmonary metastasectomyfrom osteosarcoma, and to identify the prognostic factors associatedwith the improvement of survival.
      Materials and Methods: Fifty-nine patients with pulmonary metastases from osteosarcomawere included. The prognoses of the patients were assessed by 5-yearsurvival rate, after the pulmonary metastasectomy. The prognostic factors analyzedare as follows: age, sex, location of the primary osteosarcoma, disease-free interval(DFI) from the date of primary surgery to the date of pulmonary metastases on CT,number of pulmonary metastases, maximum diameter of largest pulmonary metastaticnodule, laterality (unilateral/bilateral), and location of pulmonary metastaticnodule(s). The log-rank test was used for univariate analyses, and the Cox proportionalhazards model was used for multivariate analyses.
      Results: The 5-year survival rate was 33.89%. Multivariate analyses revealed that aDFI > 12 months [p = 0.041, hazard ratio = 0.504, 95% confidence interval (CI) =0.254--1.001] and nodule unilaterality (p = 0.029, hazard ratio = 0.291, 95% CI =0.096--0.883) were the independent prognostic factors affecting the 5-year survival.
      The 5-year survival rates of patients with a DFI > 12 months and unilaterality ofthe metastatic nodule(s) increased to 44.11% and 39.28%, respectively.
      Conclusion: The prognostic factors associated with the improved survival afterpulmonary metastasectomy from osteosarcoma were the DFI > 12 months and theunilaterality of the metastatic nodules.

      더보기

      참고문헌 (Reference)

      1 Harris MB, "Treatment of metastatic osteosarcoma at diagnosis : a Pediatric Oncology Group Study" 16 : 3641-3648, 1998

      2 Davidson RS, "The surgical management of pulmonary metastasis : current concepts" 10 : 35-42, 2001

      3 Glasser DB, "Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience" 69 : 698-708, 1992

      4 Putnam JB Jr, "Survival following aggressive resection of pulmoidlynary metastases from osteogenic sarcoma : analysis of prognostic factors" 36 : 516-523, 1983

      5 Girard P, "Surgical resection of pulmonary metastases. Up to what number?" 149 (149): 469-476, 1994

      6 Telander RL, "Resection of pulmonary metastatic osteogenic sarcoma in children" 84 : 335-341, 1978

      7 Dear RF, "Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia : 114 patients from 1978 to 2008" 8 : 292-302, 2012

      8 Internullo E, "Pulmonary metastasectomy : a survey of current practice amongst members of the European Society of Thoracic Surgeons" 3 : 1257-1266, 2008

      9 Rosen G, "Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy" 106 (106): 55-67, 1983

      10 Suzuki M, "Predictors of long-term survival with pulmonary metastasectomy for osteosarcomas and soft tissue sarcomas" 47 : 603-608, 2006

      1 Harris MB, "Treatment of metastatic osteosarcoma at diagnosis : a Pediatric Oncology Group Study" 16 : 3641-3648, 1998

      2 Davidson RS, "The surgical management of pulmonary metastasis : current concepts" 10 : 35-42, 2001

      3 Glasser DB, "Survival, prognosis, and therapeutic response in osteogenic sarcoma. The Memorial Hospital experience" 69 : 698-708, 1992

      4 Putnam JB Jr, "Survival following aggressive resection of pulmoidlynary metastases from osteogenic sarcoma : analysis of prognostic factors" 36 : 516-523, 1983

      5 Girard P, "Surgical resection of pulmonary metastases. Up to what number?" 149 (149): 469-476, 1994

      6 Telander RL, "Resection of pulmonary metastatic osteogenic sarcoma in children" 84 : 335-341, 1978

      7 Dear RF, "Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia : 114 patients from 1978 to 2008" 8 : 292-302, 2012

      8 Internullo E, "Pulmonary metastasectomy : a survey of current practice amongst members of the European Society of Thoracic Surgeons" 3 : 1257-1266, 2008

      9 Rosen G, "Primary osteogenic sarcoma: eight-year experience with adjuvant chemotherapy" 106 (106): 55-67, 1983

      10 Suzuki M, "Predictors of long-term survival with pulmonary metastasectomy for osteosarcomas and soft tissue sarcomas" 47 : 603-608, 2006

      11 Ferrari S, "Postrelapse survival in osteosarcoma of the extremities : prognostic factors for long-term survival" 21 : 710-715, 2003

      12 Hornbech K, "Outcome after pulmonary metastasectomy : analysis of 5 years consecutive surgical resections 2002-2006" 6 : 1733-1740, 2011

      13 Kempf-Bielack B, "Osteosarcoma relapse after combined modality therapy : an analysis of unselected patients in the Cooperative Osteosarcoma Study Group(COSS)" 23 : 559-568, 2005

      14 Aljubran AH, "Osteosarcoma in adolescents and adults : survival analysis with and without lung metastases" 20 : 1136-1141, 2009

      15 Temeck BK, "Metastasectomy for sarcomatous pediatric histologies: results and prognostic factors" 59 : 1385-1389, 1995

      16 Corona-Cruz JF, "Lung metastasectomy : long-term outcomes in an 18-year cohort from a single center" 21 : 237-244, 2012

      17 Bacci G, "Long-term outcome for patients with nonmetastatic osteosarcoma of the extremity treated at the istituto ortopedico rizzoli according to the istituto ortopedico rizzoli/osteosarcoma-2 protocol : an updated report" 18 : 4016-4027, 2000

      18 Timmerman RD, "Local surgical, ablative, and radiation treatment of metastases" 59 : 145-170, 2009

      19 Patel AN, "Clinical trials for pulmonary metastasectomy" 15 : 457-463, 2003

      20 Saltzman DA, "Aggressive metastasectomy for pulmonic sarcomatous metastases : a follow-up study" 166 : 543-547, 1993

      더보기

      분석정보

      View

      상세정보조회

      0

      Usage

      원문다운로드

      0

      대출신청

      0

      복사신청

      0

      EDDS신청

      0

      동일 주제 내 활용도 TOP

      더보기

      주제

      연도별 연구동향

      연도별 활용동향

      연관논문

      연구자 네트워크맵

      공동연구자 (7)

      유사연구자 (20) 활용도상위20명

      인용정보 인용지수 설명보기

      학술지 이력

      학술지 이력
      연월일 이력구분 이력상세 등재구분
      2024 평가예정 해외DB학술지평가 신청대상 (해외등재 학술지 평가)
      2021-01-01 평가 등재학술지 유지 (해외등재 학술지 평가) KCI등재
      2020-01-01 평가 등재학술지 유지 (재인증) KCI등재
      2017-01-01 평가 등재학술지 유지 (계속평가) KCI등재
      2016-11-24 학술지명변경 외국어명 : Journal of The Korean Radiological Society -> Journal of the Korean Society of Radiology (JKSR) KCI등재
      2016-11-15 학회명변경 영문명 : The Korean Radiological Society -> The Korean Society of Radiology KCI등재
      2013-01-01 평가 등재 1차 FAIL (등재유지) KCI등재
      2010-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2008-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2006-01-01 평가 등재학술지 유지 (등재유지) KCI등재
      2005-09-15 학술지명변경 한글명 : 대한방사선의학회지 -> 대한영상의학회지 KCI등재
      2003-01-01 평가 등재학술지 선정 (등재후보2차) KCI등재
      2002-01-01 평가 등재후보 1차 PASS (등재후보1차) KCI등재후보
      2000-07-01 평가 등재후보학술지 선정 (신규평가) KCI등재후보
      더보기

      학술지 인용정보

      학술지 인용정보
      기준연도 WOS-KCI 통합IF(2년) KCIF(2년) KCIF(3년)
      2016 0.1 0.1 0.07
      KCIF(4년) KCIF(5년) 중심성지수(3년) 즉시성지수
      0.06 0.05 0.258 0.01
      더보기

      이 자료와 함께 이용한 RISS 자료

      나만을 위한 추천자료

      해외이동버튼